Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Changes In Shareholders' Equity

v3.21.1
Condensed Statement of Changes In Shareholders' Equity - 3 months ended Mar. 31, 2021 - USD ($)
Total
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Common Class A [Member]
Common Class B [Member]
Beginning Balance at Dec. 31, 2020 $ 9,070 $ 23,749 $ (15,930)   $ 1,251
Beginning Balance , Shares at Dec. 31, 2020 [1]         12,506,250
Sale of units in initial public offering, less fair value of public warrants 484,899,900 484,894,941   $ 4,959  
Sale of units in initial public offering, less fair value of public warrants , Shares       49,590,908  
Offering costs (27,340,317) (27,340,317)      
Excess of cash received over fair value of private placement warrant 3,540,732 3,540,732      
Shares subject to possible redemption (458,411,930) (458,407,346)   $ (4,584)  
Shares subject to possible redemption , Shares       (45,841,193)  
Net income 2,302,546   2,302,546    
Ending Balance at Mar. 31, 2021 $ 5,000,001 $ 2,711,759 $ 2,286,616 $ 375 $ 1,251
Ending Balance , Shares at Mar. 31, 2021       3,749,715 12,506,250 [1]
[1] This number included up to 1,631,250 Class B ordinary shares subject to forfeiture if the over-allotment option was not exercised in full or in part by the underwriters. On March 9, 2021, the underwriters partially exercised the over-allotment option to purchase an additional 6,090,908 Units; leaving only 108,523 Class B ordinary shares remain subject to forfeiture. On April 22, 2021, the underwriters’ over-allotment option expired, and the Sponsor forfeited 108,523 shares of Class B ordinary shares accordingly.